Christoph Westphal
2016 - Flex Pharma
In 2016, Christoph Westphal earned a total compensation of $1.7M as President, Chief Executive Officer, Chair of the Board at Flex Pharma, a 142% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $200,927 |
|---|---|
| Option Awards | $996,808 |
| Salary | $472,770 |
| Other | $15,914 |
| Total | $1,686,419 |
Westphal received $996.8K in option awards, accounting for 59% of the total pay in 2016.
Westphal also received $200.9K in non-equity incentive plan, $472.8K in salary and $15.9K in other compensation.
Rankings
In 2016, Christoph Westphal's compensation ranked 5,677th out of 14,075 executives tracked by ExecPay. In other words, Westphal earned more than 59.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,677 out of 14,075 | 60th |
Division Manufacturing | 2,056 out of 5,486 | 63rd |
Major group Chemicals And Allied Products | 658 out of 1,900 | 65th |
Industry group Drugs | 494 out of 1,543 | 68th |
Industry Pharmaceutical Preparations | 393 out of 1,173 | 67th |
Source: SEC filing on April 19, 2017.
Westphal's colleagues
We found two more compensation records of executives who worked with Christoph Westphal at Flex Pharma in 2016.